IPC-Stelle: C12N 15/869 [Version 7 (gültig ab 01.2000)]

SymbolTypTitel
CSKCHEMISTRY; METALLURGY
C12KLBIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12NUKLMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, enzymes, fermentates, or substances produced by, or extracted from, micro-organisms or animal material A01N 63/00; food compositions A21 , A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N 1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q) [3]
C12N 1/00HGRMicro-organisms, e.g. protozoa; Compositions thereof (medicinal preparations containing material from micro-organisms A61K 35/66; preparing medicinal bacterial antigen or antibody compositions, e.g. bacterial vaccines, A61K 39/00); Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor [3]
C12N 1/02UGR1
.Separating micro-organisms from their culture media [3]
C12N 1/04UGR1
.Preserving or maintaining viable micro-organisms (immobilised micro-organisms C12N 11/00) [3]
C12N 1/06UGR1
.Lysis of micro-organisms [3]
C12N 1/08UGR1
.Reducing the nucleic acid content [3]
C12N 1/10UGR1
.Protozoa; Culture media therefor [3]
C12N 1/11UGR2
. .modified by introduction of foreign genetic material [5]
C12N 1/12UGR1
.Unicellular algae; Culture media therefor (culture of multi-cellular plants A01G; as new plants A01H 13/00) [3]
C12N 1/13UGR2
. .modified by introduction of foreign genetic material [5]
C12N 1/14UGR1
.Fungi (culture of mushrooms A01G 1/04; as new plants A01H 15/00); Culture media therefor [3]
C12N 1/15UGR2
. .modified by introduction of foreign genetic material [5]
C12N 1/16UGR2
. .Yeasts; Culture media therefor [3]
C12N 1/18UGR3
. . .Baker's yeast; Brewer's yeast [3]
C12N 1/19UGR3
. . .modified by introduction of foreign genetic material [5]
C12N 1/20UGR1
.Bacteria; Culture media therefor [3]
C12N 1/21UGR2
. .modified by introduction of foreign genetic material [5]
C12N 1/22UGR1
.Processes using, or culture media containing, cellulose or hydrolysates thereof [3]
C12N 1/24UGR1
.Processes using, or culture media containing, waste sulfite liquor [3]
C12N 1/26UGR1
.Processes using, or culture media containing, hydrocarbons (refining of hydrocarbon oils by using micro-organisms C10G 32/00) [3]
C12N 1/28UGR2
. .aliphatic [3]
C12N 1/30UGR3
. . .having five or less carbon atoms [3]
C12N 1/32UGR1
.Processes using, or culture media containing, lower alkanols, i.e. C_1_ to C_6_ [3]
C12N 1/34UGR1
.Processes using foam culture [3]
C12N 1/36UGR1
.Adaptation or attenuation of cells [3]
C12N 1/38UGR1
.Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound (C12N 1/34 takes precedence) [3]
C12N 3/00HGRSpore-forming or isolating processes [3]
C12N 5/00HGRUndifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (plant reproduction by tissue culture techniques A01H 4/00) [3, 5]
C12N 5/02UGR1
.Propagation of single cells or cells in suspension; Maintenance thereof; Culture media therefor [3]
C12N 5/04UGR1
.Plant cells or tissues [5]
C12N 5/06UGR1
.Animal cells or tissues [5]
C12N 5/08UGR1
.Human cells or tissues [5]
C12N 5/10UGR1
.Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells [5]
C12N 5/12UGR2
. .Fused cells, e.g. hybridomas [5]
C12N 5/14UGR3
. . .Plant cells [5]
C12N 5/16UGR3
. . .Animal cells [5]
C12N 5/18UGR4
. . . .Murine cells, e.g. mouse cells [5]
C12N 5/20UGR5
. . . . .one of the fusion partners being a B lymphocyte [5]
C12N 5/22UGR3
. . .Human cells [5]
C12N 5/24UGR4
. . . .one of the fusion partners being a B lymphocyte [5]
C12N 5/26UGR3
. . .Cells resulting from interspecies fusion [5]
C12N 5/28UGR4
. . . .one of the fusion partners being a human cell [5]
C12N 7/00HGRViruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (medicinal preparations containing viruses A61K 35/76; preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K 39/00) [3]
C12N 7/01UGR1
.Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material (vectors C12N 15/00) [5]
C12N 7/02UGR1
.Recovery or purification [3]
C12N 7/04UGR1
.Inactivation or attenuation; Producing viral sub-units [3]
C12N 7/06UGR2
. .by chemical treatment [3]
C12N 7/08UGR2
. .by serial passage of virus [3]
C12N 9/00HGREnzymes, e.g. ligases (6.); Proenzymes; Compositions thereof (preparations containing enzymes for cleaning teeth A61K 7/28; medicinal preparations containing enzymes or proenzymes A61K 38/43; enzyme containing detergent compositions C11D); Processes for preparing, activating, inhibiting, separating, or purifying enzymes (preparation of malt C12C 1/00) [3]
C12N 9/02UGR1
.Oxidoreductases (1.), e.g. luciferase [3]
C12N 9/04UGR2
. .acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1) [3]
C12N 9/06UGR2
. .acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) [3]
C12N 9/08UGR2
. .acting on hydrogen peroxide as acceptor (1.11) [3]
C12N 9/10UGR1
.Transferases (2.) (ribonucleases C12N 9/22) [3]
C12N 9/12UGR2
. .transferring phosphorus containing groups, e.g. kinases (2.7) [3]
C12N 9/14UGR1
.Hydrolases (3.) [3]
C12N 9/16UGR2
. .acting on ester bonds (3.1) [3]
C12N 9/18UGR3
. . .Carboxylic ester hydrolases [3]
C12N 9/20UGR4
. . . .Triglyceride splitting, e.g. by means of lipase [3]
C12N 9/22UGR3
. . .Ribonucleases [3]
C12N 9/24UGR2
. .acting on glycosyl compounds (3.2) [3]
C12N 9/26UGR3
. . .acting on alpha-1, 4-glucosidic bonds, e.g. hyaluronidase, invertase, amylase [3]
C12N 9/28UGR4
. . . .Alpha-amylase from microbial source, e.g. bacterial amylase [3]
C12N 9/30UGR5
. . . . .Fungal source [3]
C12N 9/32UGR4
. . . .Alpha-amylase from plant source [3]
C12N 9/34UGR4
. . . .Glucoamylase [3]
C12N 9/36UGR3
. . .acting on beta-1, 4 bonds between N-acetylmuramic acid and 2-acetylamino 2-deoxy-D-glucose, e.g. lysozyme [3]
C12N 9/38UGR3
. . .acting on beta-galactose-glycoside bonds, e.g. beta-galactosidase [3]
C12N 9/40UGR3
. . .acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase [3]
C12N 9/42UGR3
. . .acting on beta-1, 4-glucosidic bonds, e.g. cellulase [3]
C12N 9/44UGR3
. . .acting on alpha-1, 6-glucosidic bonds, e.g. isoamylase, pullulanase [3]
C12N 9/46UGR4
. . . .Dextranase [3]
C12N 9/48UGR2
. .acting on peptide bonds, e.g. thromboplastin, leucine aminopeptidase (3.4) [3]
C12N 9/50UGR3
. . .Proteinases [3]
C12N 9/52UGR4
. . . .derived from bacteria [3]
C12N 9/54UGR5
. . . . .bacteria being Bacillus [3]
C12N 9/56UGR6
. . . . . .Bacillus subtilis or Bacillus licheniformis [3]
C12N 9/58UGR4
. . . .derived from fungi [3]
C12N 9/60UGR5
. . . . .from yeast [3]
C12N 9/62UGR5
. . . . .from Aspergillus [3]
C12N 9/64UGR4
. . . .derived from animal tissue, e.g. rennin [3]
C12N 9/66UGR3
. . .Elastase [3]
C12N 9/68UGR3
. . .Plasmin, i.e. fibrinolysin [3]
C12N 9/70UGR3
. . .Streptokinase [3]
C12N 9/72UGR3
. . .Urokinase [3]
C12N 9/74UGR3
. . .Thrombin [3]
C12N 9/76UGR3
. . .Trypsin; Chymotrypsin [3]
C12N 9/78UGR2
. .acting on carbon to nitrogen bonds other than peptide bonds (3.5) [3]
C12N 9/80UGR3
. . .acting on amide bonds in linear amides [3]
C12N 9/82UGR4
. . . .Asparaginase [3]
C12N 9/84UGR4
. . . .Penicillin amidase [3]
C12N 9/86UGR3
. . .acting on amide bonds in cyclic amides, e.g. penicillinase [3]
C12N 9/88UGR1
.Lyases (4.) [3]
C12N 9/90UGR1
.Isomerases (5.) [3]
C12N 9/92UGR2
. .Glucose isomerase [3]
C12N 9/94UGR1
.Pancreatin [3]
C12N 9/96UGR1
.Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates [3]
C12N 9/98UGR1
.Preparation of granular or free-flowing enzyme compositions (C12N 9/96 takes precedence) [3]
C12N 9/99UGR1
.Enzyme inactivation by chemical treatment [3]
C12N 11/00HGRCarrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof [3]
C12N 11/02UGR1
.Enzymes or microbial cells being immobilised on or in an organic carrier [3]
C12N 11/04UGR2
. .entrapped within the carrier, e.g. gel, hollow fibre [3]
C12N 11/06UGR2
. .attached to the carrier via a bridging agent [3]
C12N 11/08UGR2
. .the carrier being a synthetic polymer [3]
C12N 11/10UGR2
. .the carrier being a carbohydrate [3]
C12N 11/12UGR3
. . .Cellulose or derivatives thereof [3]
C12N 11/14UGR1
.Enzymes or microbial cells being immobilised on or in an inorganic carrier [3]
C12N 11/16UGR1
.Enzymes or microbial cells being immobilised on or in a biological cell [3]
C12N 11/18UGR1
.Multi-enzyme systems [3]
C12N 13/00HGRTreatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves [3]
C12N 15/00HGRMutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered micro-organisms C12N 1/00 , C12N 5/00 , C12N 7/00; new plants A01H; plant reproduction by tissue culture techniques A01H 4/00; new animals A01K 67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K 48/00; peptides in general C07K) [3, 5, 6]
C12N 15/01UGR1
.Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor [5]
C12N 15/02UGR1
.Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion [5]
C12N 15/03UGR2
. .Bacteria [5]
C12N 15/04UGR2
. .Fungi [5]
C12N 15/05UGR2
. .Plant cells [5]
C12N 15/06UGR2
. .Animal cells [5]
C12N 15/07UGR2
. .Human cells [5]
C12N 15/08UGR2
. .Cells resulting from interspecies fusion [5]
C12N 15/09UGR1
.Recombinant DNA-technology [5]
C12N 15/10UGR2
. .Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H 21/00; preparation of non-structural polynucleotides from micro-organisms or with enzymes C12P 19/34) [5]
C12N 15/11UGR2
. .DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology C07H 21/00) [5]
C12N 15/12UGR3
. . .Genes encoding animal proteins [5]
C12N 15/13UGR4
. . . .Immunoglobulins [5]
C12N 15/14UGR4
. . . .Human serum albumins [5]
C12N 15/15UGR4
. . . .Protease inhibitors, e.g. antithrombin, antitrypsin, hirudin [5]
C12N 15/16UGR4
. . . .Hormones [5]
C12N 15/17UGR5
. . . . .Insulins [5]
C12N 15/18UGR5
. . . . .Growth hormones [5]
C12N 15/19UGR4
. . . .Interferons; Lymphokines; Cytokines [5]
C12N 15/20UGR5
. . . . .Interferons [5]
C12N 15/21UGR6
. . . . . .Alpha-interferons [5]
C12N 15/22UGR6
. . . . . .Beta-interferons [5]
C12N 15/23UGR6
. . . . . .Gamma-interferons [5]
C12N 15/24UGR5
. . . . .Interleukins [5]
C12N 15/25UGR6
. . . . . .Interleukin-1 [5]
C12N 15/26UGR6
. . . . . .Interleukin-2 [5]
C12N 15/27UGR5
. . . . .Colony stimulating factors [5]
C12N 15/28UGR5
. . . . .Tumor necrosis factors [5]
C12N 15/29UGR3
. . .Genes encoding plant proteins, e.g. thaumatin [5]
C12N 15/30UGR3
. . .Genes encoding protozoal proteins, e.g. from Plasmodium, Trypanosoma, Eimeria [5]
C12N 15/31UGR3
. . .Genes encoding microbial proteins, e.g. enterotoxins [5]
C12N 15/32UGR4
. . . .Bacillus crystal proteins [5]
C12N 15/33UGR4
. . . .Genes encoding viral proteins [5]
C12N 15/34UGR5
. . . . .Proteins from DNA viruses [5]
C12N 15/35UGR6
. . . . . .Parvoviridae, e.g. feline panleukopenia virus, human parvovirus [5]
C12N 15/36UGR6
. . . . . .Hepadnaviridae [5]
C12N 15/37UGR6
. . . . . .Papovaviridae, e.g. papillomaviruses, polyomavirus, SV40 [5]
C12N 15/38UGR6
. . . . . .Herpetoviridae, e.g. herpes simplex virus, varicella-zoster virus, Epstein-Barr virus, cytomegalovirus, pseudorabies virus [5]
C12N 15/39UGR6
. . . . . .Poxviridae, e.g. vaccinia virus, variola virus [5]
C12N 15/40UGR5
. . . . .Proteins from RNA viruses, e.g. flaviviruses [5]
C12N 15/41UGR6
. . . . . .Picornaviridae, e.g. rhinovirus, coxsackie viruses, echoviruses, enteroviruses [5]
C12N 15/42UGR7
. . . . . . .Foot-and-mouth disease virus [5]
C12N 15/43UGR7
. . . . . . .Poliovirus [5]
C12N 15/44UGR6
. . . . . .Orthomyxoviridae, e.g. influenza virus [5]
C12N 15/45UGR6
. . . . . .Paramyxoviridae, e.g. measles virus, mumps virus, Newcastle disease virus, canine distemper virus, rinderpest virus, respiratory syncytial viruses [5]
C12N 15/46UGR6
. . . . . .Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus [5]
C12N 15/47UGR6
. . . . . .Rhabdoviridae, e.g. rabies viruses, vesicular stomatitis virus [5]
C12N 15/48UGR6
. . . . . .Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, HIV [5]
C12N 15/49UGR7
. . . . . . .Lentiviridae, e.g. immunodeficiency viruses, visna-maedi virus, equine infectious anaemia virus [5]
C12N 15/50UGR6
. . . . . .Coronaviridae, e.g. infectious bronchitis virus, transmissible gastroenteritis virus [5]
C12N 15/51UGR5
. . . . .Hepatitis viruses [5]
C12N 15/52UGR3
. . .Genes encoding for enzymes or proenzymes [5]
C12N 15/53UGR4
. . . .Oxidoreductases (1) [5]
C12N 15/54UGR4
. . . .Transferases (2) [5]
C12N 15/55UGR4
. . . .Hydrolases (3) [5]
C12N 15/56UGR5
. . . . .acting on glycosyl compounds (3.2), e.g. amylase, galactosidase, lysozyme [5]
C12N 15/57UGR5
. . . . .acting on peptide bonds (3.4) [5]
C12N 15/58UGR6
. . . . . .Plasminogen activators, e.g. urokinase, TPA [5]
C12N 15/59UGR6
. . . . . .Chymosin [5]
C12N 15/60UGR4
. . . .Lyases (4) [5]
C12N 15/61UGR4
. . . .Isomerases (5) [5]
C12N 15/62UGR3
. . .DNA sequences coding for fusion proteins [5]
C12N 15/63UGR2
. .Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression [5]
C12N 15/64UGR3
. . .General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host [5]
C12N 15/65UGR3
. . .using markers (enzymes used as markers C12N 15/52) [5]
C12N 15/66UGR3
. . .General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease [5]
C12N 15/67UGR3
. . .General methods for enhancing the expression [5]
C12N 15/68UGR4
. . . .Stabilisation of the vector [5]
C12N 15/69UGR4
. . . .Increasing the copy number of the vector [5]
C12N 15/70UGR3
. . .Vectors or expression systems specially adapted for E. coli [5]
C12N 15/71UGR4
. . . .Expression systems using regulatory sequences derived from the trp-operon [5]
C12N 15/72UGR4
. . . .Expression systems using regulatory sequences derived from the lac-operon [5]
C12N 15/73UGR4
. . . .Expression systems using phage lambda regulatory sequences [5]
C12N 15/74UGR3
. . .Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora [5]
C12N 15/75UGR4
. . . .for Bacillus [5]
C12N 15/76UGR4
. . . .for Actinomyces; for Streptomyces [5]
C12N 15/77UGR4
. . . .for Corynebacterium; for Brevibacterium [5]
C12N 15/78UGR4
. . . .for Pseudomonas [5]
C12N 15/79UGR3
. . .Vectors or expression systems specially adapted for eukaryotic hosts;  [5]
C12N 15/80UGR4
. . . .for fungi [5]
C12N 15/81UGR5
. . . . .for yeasts [5]
C12N 15/82UGR4
. . . .for plant cells [5]
C12N 15/83UGR5
. . . . .Viral vectors, e.g. cauliflower mosaic virus [5]
C12N 15/84UGR5
. . . . .Ti-plasmids [5]
C12N 15/85UGR4
. . . .for animal cells [5]
C12N 15/86UGR5
. . . . .Viral vectors [5]
C12N 15/861UGR6
. . . . . .Adenoviral vectors [7]
C12N 15/863UGR6
. . . . . .Poxviral vectors, e.g. vaccinia virus [7]
C12N 15/864UGR6
. . . . . .Parvoviral vectors [7]
C12N 15/866UGR6
. . . . . .Baculoviral vectors [7]
C12N 15/867UGR6
. . . . . .Retroviral vectors [7]
C12N 15/869UGR6
. . . . . .Herpesviral vectors [7]
C12N 15/87UGR2
. .Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation [5]
C12N 15/88UGR3
. . .using micro-encapsulation, e.g. using liposome vesicle [5]
C12N 15/89UGR3
. . .using micro-injection [5]
C12N 15/90UGR3
. . .Stable introduction of foreign DNA into chromosome [5]